At the forefront, our potential step changes in treatment ... exacerbation data competitive with Dupixent and have you shown an FEV benefit, I mean, if not, your statements that you will lead in ...

Possible treatment options for end stage lung disease include ... OUTCOME OF MECHANICAL VENTILATION IN ACUTE EXACERBATIONS OF COPD Lynn et al 11 have looked at the experiences of patients with COPD ...

Emergency department presentations due to asthma exacerbations ... standardized approach to diagnosis and treatment, potentially supported by clinical decision aids, as has been applied in the ...

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

Researchers found that the risk for moderate or severe COPD exacerbation ... severe COPD exacerbations among patients aged 40 years or older with T2D and active COPD who initiated treatment ...

Lower risk for COPD exacerbations ... for moderate or severe COPD exacerbations among patients aged 40 years or older with T2D and active COPD who initiated treatment with SGLT-2is versus DPP ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.

“This could influence treatment decisions and improve respiratory health in this high-risk population.” “GLP-1 medications might help lower COPD exacerbation risk by reducing systemic ...

This submission is based on the Phase III MATINEE trial, which demonstrated a significant reduction in the rate of moderate/severe exacerbations compared to placebo. COPD, a progressive lung ...